October 19th 2022
Cancer vaccine could be available by 2030, COVID vax-makers say
by New York Post
A vaccine for cancer may be a reality within the decade, according to the husband and wife duo behind the successful Pfizer/BioNtech COVID-19 vaccine.
Professors Ugur Sahin and Ozlem Tureci, co-founders of the German company BioNTech, have been researching new technology for years involving messenger RNA [mRNA] that they are hopeful could treat various types of cancers.
Sahin told the BBC that he believes a cancer vaccine could be widely available “before 2030.”
Several trials for the vaccine are already underway, which started long before the pandemic and have already shown signs of promise.
BioNTech, founded in 2008, partnered with US pharma giant Pfizer during the COVID-19 pandemic to use its mRNA technology to develop a vaccine for the virus in a matter of months thanks to the breakthrough in mRNA vaccines — which teach human cells how to make a protein that will trigger an immune response.
The married couple hopes the proven success of the mRNA vaccines against the coronavirus can be effective in treating cancers, such as melanoma, bowel cancer and others.
“What we have developed over decades for cancer vaccine development has been the tailwind for developing the COVID-19 vaccine, and now the Covid-19 vaccine and our experience in developing it gives back to our cancer work,” Tureci said.
“mRNA acts as a blueprint and allows you to tell the body to produce the drug or the vaccine … and when you use mRNA as a vaccine, the mRNA is a blueprint for the ‘wanted poster’ of the enemy — in this case, cancer antigens which distinguish cancer cells from normal cells.”
While it may be years before the vaccine can be touted as a “cure” for cancer, researchers are learning more about how to fight the disease with each trial.
TO RECEIVE NEWS NOTIFICATIONS VIA WHATS APP PLEASE SAVE OUR NUMBER AND SEND US A MESSAGE AT 7584896261 AND WE WILL ADD YOU TO OUR LIST
